Ocular Surface Disease clinical trials at UCLA

1 research study open to eligible people

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
open to all eligible people
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Fountain Valley, California

Our lead scientists for Ocular Surface Disease research studies include Benjamin Bert.

Last updated: October 2022

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications